Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.

Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN; Liver Match Investigators..

J Hepatol. 2013 Apr;58(4):715-23. doi: 10.1016/j.jhep.2012.11.025. Epub 2012 Nov 28.

PMID:
23201239
3.

Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.

Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B.

Clin Transplant. 2011 Jan-Feb;25(1):E77-81. doi: 10.1111/j.1399-0012.2010.01329.x. Epub 2010 Oct 11.

PMID:
21039887
4.

Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity.

Tandoi F, Romagnoli R, Martini S, Mazza E, Nada E, Cocchis D, Lupo F, Salizzoni M.

Transplant Proc. 2012 Sep;44(7):1960-2. doi: 10.1016/j.transproceed.2012.07.061.

PMID:
22974882
5.

Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.

Skagen CL, Jou JH, Said A.

Clin Transplant. 2011 May-Jun;25(3):E243-9. doi: 10.1111/j.1399-0012.2011.01409.x. Epub 2011 Feb 16.

PMID:
21323735
6.

Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.

Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, Costa AN, Nardi A, Strazzabosco M, Burra P, Agnes S, Baccarani U, Calise F, Colledan M, Cuomo O, De Carlis L, Donataccio M, Ettorre GM, Gerunda GE, Gridelli B, Lupo L, Mazzaferro V, Pinna A, Risaliti A, Salizzoni M, Tisone G, Valente U, Rossi G, Rossi M, Zamboni F; Liver Match Investigators..

Dig Liver Dis. 2011 Feb;43(2):155-64. doi: 10.1016/j.dld.2010.11.002. Epub 2010 Dec 24.

PMID:
21185796
7.

Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors.

Chang MS, Olsen SK, Pichardo EM, Heese S, Stiles JB, Abdelmessih R, Verna EC, Guarrera JV, Emond JC, Brown RS Jr.

Liver Transpl. 2012 Jul;18(7):834-8. doi: 10.1002/lt.23429.

8.

Outcomes of liver transplantation from hepatitis B core antibody-positive donors in viral cirrhosis patients: the prevailing negative effect of recipient hepatitis C virus infection.

Tandoi F, Romagnoli R, Martini S, Mazza E, Nada E, Cocchis D, Lupo F, Salizzoni M.

Transplant Proc. 2012 Sep;44(7):1963-5. doi: 10.1016/j.transproceed.2012.05.064.

PMID:
22974883
9.

Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.

Madayag RM, Johnson LB, Bartlett ST, Schweitzer EJ, Constantine NT, McCarter RJ Jr, Kuo PC, Keay S, Oldach DW.

Transplantation. 1997 Dec 27;64(12):1781-6.

PMID:
9422420
10.

Liver transplantation of hepatitis B surface antigen positive donors to hepatitis B core antibody recipients: analysis of 27 patients.

Krishnamoorthi R, Manickam P, Cappell MS.

Minerva Gastroenterol Dietol. 2014 Jun;60(2):113-8.

PMID:
24780945
11.

Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.

Bohorquez HE, Cohen AJ, Girgrah N, Bruce DS, Carmody IC, Joshi S, Reichman TW, Therapondos G, Mason AL, Loss GE.

Liver Transpl. 2013 Jun;19(6):611-8. doi: 10.1002/lt.23644.

12.

De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.

Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.

Liver Transpl. 2001 Jan;7(1):51-8.

13.

Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.

Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW.

Liver Transpl. 2003 Oct;9(10):1053-61.

14.

Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.

Veroux M, Corona D, Ekser B, Giaquinta A, Tallarita T, De Martino C, Gentile F, Virgilio C, Gagliano M, Fiamingo P, Veroux P.

Transplant Proc. 2011 May;43(4):967-70. doi: 10.1016/j.transproceed.2011.01.155.

PMID:
21620027
15.

Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors.

Satterthwaite R, Ozgu I, Shidban H, Aswad S, Sunga V, Zapanta R Jr, Asai P, Bogaard T, Khetan U, Mendez RG, Mendez R.

Transplantation. 1997 Aug 15;64(3):432-5.

PMID:
9275109
16.

Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.

Chang MS, Olsen SK, Pichardo EM, Stiles JB, Rosenthal-Cogan L, Brubaker WD, Guarrera JV, Emond JC, Brown RS Jr.

Transplantation. 2013 Apr 15;95(7):960-5. doi: 10.1097/TP.0b013e3182845f97.

PMID:
23545507
17.

Safe use of livers from donors with positive hepatitis B core antibody.

Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ.

Liver Transpl. 2002 Jun;8(6):556-61.

18.

Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.

Veroux M, Puliatti C, Gagliano M, Cappello D, Macarone M, Vizcarra D, Spataro M, Di Mare M, Ginevra N, Veroux P.

Transplant Proc. 2005 Jul-Aug;37(6):2574-5.

PMID:
16182748
19.

Prognostic implications of recipient or donor hepatitis B seropositivity in thoracic transplantation: analysis of 426 hepatitis B surface antigen-positive recipients.

Manickam P, Krishnamoorthi R, Kanaan Z, Gunasekaran PK, Cappell MS.

Transpl Infect Dis. 2014 Aug;16(4):597-604. doi: 10.1111/tid.12256. Epub 2014 Jul 1.

PMID:
24980920
20.

Utilization of hepatitis B core antibody-positive donor liver grafts.

MacConmara MP, Vachharajani N, Wellen JR, Anderson CD, Lowell JA, Shenoy S, Chapman WC, Doyle MB.

HPB (Oxford). 2012 Jan;14(1):42-8. doi: 10.1111/j.1477-2574.2011.00399.x. Epub 2011 Nov 2.

Supplemental Content

Support Center